Description
HER2/neu (869-877) is a peptide fragment of the HER2/neu receptor, also known as CD340, EGFR2, or erbB2. This receptor exhibits anti-apoptotic activity and is associated with breast and other cancers.
| Product Unit Size | Cost | Quantity | Stock |
|---|
HER2/neu (869-877) is a peptide fragment of the HER2/neu receptor, also known as CD340, EGFR2, or erbB2. This receptor exhibits anti-apoptotic activity and is associated with breast and other cancers.
| Purity | ≥95% |
|---|---|
| Formula | C49H75N9O20 |
| Formula Wt. | 1110.19 |
| Synonym | ErbB2, EGFR2 |
| Solubility | Soluble in water. |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Mitri Z, Constantine T, O'Regan R. The HER2 Receptor in Breast Cancer: Pathophysiology, Clinical Use, and New Advances in Therapy. Chemother Res Pract. 2012;2012:743193. PMID: 23320171.
Roy V, Perez EA. Beyond trastuzumab: small molecule tyrosine kinase inhibitors in HER-2-positive breast cancer. Oncologist. 2009 Nov;14(11):1061-9. PMID: 19887469.
Epoxomicin analog; proteasome inhibitor.
AurKA inhibitor.
SRPK1 inhibitor.
ATP competitive CDK inhibitor.
MAGL inhibitor.
Xanthine oxidase inhibitor.
Fluoroquinolone; bacterial DNA gyrase inhibitor...
Galactose-derived hexosamine sugar, component o...
PI3K and PDK1 inhibitor.
Oxidized non-cylic hexose sugar.
Hydroxycinnamic acid found in coffee, argan oil...
Sesquiterpene alkaloid found in Huperzia serrat...
FAK inhibitor.
Polyanionic sulfated glycosaminoglycan, endogen...
VEGFR, PDGFR, c-Kit, RET inhibitor.
PKC and PKG inhibitor.
Podophyllotoxin derivative; topoisomerase II in...
TRPA1 agonist, xanthine oxidase inhibitor.
Multikinase inhibitor.